Survival from most cancers has improved, but international variations persist, with poorer survival in the United Kingdom than other developed countries. Variations in outcomes manifest soon after diagnosis. For example, socioeconomic variations in survival from colorectal cancers are largely confined to excess mortality in the postoperative period, and international variations in breast cancer survival are most pronounced in the first month and year after diagnosis.
1,2 However, it remains unclear what mediates better survival. It has been suggested that quality of health care may explain international variations in cancer outcomes.
3 While this is often considered in terms of availability and effectiveness of therapeutic interventions, the role of supportive care to prevent or ameliorate critical illness among patients with cancer may also be important.